Clobetasone Butyrate

54063-32-0 Category:
  • # LGM Pharma is a Clobetasone Butyrate CAS# 54063-32-0 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Clobetasone Butyrate
  • CAS #: 54063-32-0
  • IUPAC: (1R, 2S, 10S, 11S, 13S, 14R, 15S)-14-(2-chloroacetyl)-1-fluoro-14-hydroxy-2, 13, 15-trimethyltetracyclo[, 7.011, 15]heptadeca-3, 6-diene-5, 17-dione
  • ATC: D07AB01 S01BA09
  • PubChem: 71387
  • Formula: C22H26O4
  • Molecular Mass: 408.891
  • Synonyms: 21-Chloro-9-fluoro-17-hydroxy-16-beta-methylpregna-1,4-diene,3,11,20-trione butyrate, 21-Chloro-9-fluoro-17-hydroxy-16beta-methylpregna-1,4-diene-3,11,20-trione butyrate, CCI 5537, Clobetasone 17-butyrate, Clobetasone butyrate, Cloptison, EINECS 246-635-9, Emovate, Eumovate, GR 2/1214, Molivate, Pregna-1,4-diene-3,11,20-trione, 21-chloro-9-fluoro-16-methyl-17-(1-oxobutoxy)-, (16-beta)-, SN 203, UNII-8U0H6XI6EO
  • SMILES: C=1C(=O)C=C2[C@@](C1)([C@@]1([C@@H](CC2)[C@@H]2C[C@@H]([C@@]([C@@]2(C)CC1=O)(C(CCl)=O)OC(CCC)=O)C)F)C
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants


  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service